Please wait...
About This Project
Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Dermatology AI Assistant to Empower Primary Care Providers in Zaatari Refugee Camp in Jordan
An AI-assisted dermatology tool for refugees, utilizing imaging and symptom questionnaires to improve diagnostic...
Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia
Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...
NoAAC Longitudinal Registry of Treatment Outcomes in iSGS
Idiopathic subglottic stenosis (iSGS) is a rare and life-threatening disease involving airway obstruction...